Owens & Minor Target of Unusually High Options Trading (NYSE:OMI)

Owens & Minor, Inc. (NYSE:OMI) saw unusually large options trading activity on Monday. Traders purchased 9,860 call options on the stock. This represents an increase of 1,549% compared to the average volume of 598 call options.

Owens & Minor Stock Performance

NYSE OMI opened at $19.21 on Tuesday. The firm has a market capitalization of $1.47 billion, a P/E ratio of -37.67, a price-to-earnings-growth ratio of 0.57 and a beta of 0.52. The company has a current ratio of 1.16, a quick ratio of 0.56 and a debt-to-equity ratio of 2.17. The firm’s fifty day moving average price is $25.35 and its two-hundred day moving average price is $21.49. Owens & Minor has a 1 year low of $13.64 and a 1 year high of $28.35.

Owens & Minor (NYSE:OMI) last issued its earnings results on Friday, May 3rd. The company reported $0.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.17 by $0.02. The business had revenue of $2.61 billion during the quarter, compared to the consensus estimate of $2.61 billion. Owens & Minor had a negative net margin of 0.37% and a positive return on equity of 12.97%. Owens & Minor’s revenue was up 3.6% on a year-over-year basis. During the same period last year, the business posted $0.05 EPS. As a group, research analysts anticipate that Owens & Minor will post 1.54 EPS for the current year.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on OMI. Barclays lifted their price target on shares of Owens & Minor from $21.00 to $23.00 and gave the company an “equal weight” rating in a report on Wednesday, February 21st. Leerink Partnrs reaffirmed a “market perform” rating on shares of Owens & Minor in a research note on Monday, February 26th. Robert W. Baird dropped their target price on shares of Owens & Minor from $28.00 to $24.00 and set a “neutral” rating for the company in a research note on Monday. StockNews.com upgraded shares of Owens & Minor from a “hold” rating to a “buy” rating in a research report on Wednesday, February 21st. Finally, SVB Leerink assumed coverage on shares of Owens & Minor in a report on Monday, February 26th. They set a “market perform” rating and a $24.00 price objective for the company. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $23.29.

Insiders Place Their Bets

In other Owens & Minor news, SVP Michael Wayne Lowry sold 10,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 27th. The stock was sold at an average price of $25.00, for a total value of $250,000.00. Following the completion of the transaction, the senior vice president now owns 71,654 shares of the company’s stock, valued at approximately $1,791,350. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In related news, SVP Jonathan A. Leon sold 5,000 shares of Owens & Minor stock in a transaction dated Monday, April 22nd. The shares were sold at an average price of $24.84, for a total transaction of $124,200.00. Following the completion of the transaction, the senior vice president now directly owns 84,673 shares of the company’s stock, valued at approximately $2,103,277.32. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Michael Wayne Lowry sold 10,000 shares of Owens & Minor stock in a transaction dated Tuesday, February 27th. The shares were sold at an average price of $25.00, for a total transaction of $250,000.00. Following the transaction, the senior vice president now directly owns 71,654 shares of the company’s stock, valued at $1,791,350. The disclosure for this sale can be found here. Company insiders own 2.62% of the company’s stock.

Hedge Funds Weigh In On Owens & Minor

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Riverview Trust Co acquired a new position in shares of Owens & Minor in the first quarter valued at about $25,000. Hexagon Capital Partners LLC grew its stake in shares of Owens & Minor by 1,240.2% in the first quarter. Hexagon Capital Partners LLC now owns 1,568 shares of the company’s stock valued at $43,000 after acquiring an additional 1,451 shares in the last quarter. GAMMA Investing LLC grew its stake in shares of Owens & Minor by 52.1% in the first quarter. GAMMA Investing LLC now owns 1,644 shares of the company’s stock valued at $46,000 after acquiring an additional 563 shares in the last quarter. DekaBank Deutsche Girozentrale acquired a new position in shares of Owens & Minor in the third quarter valued at about $29,000. Finally, Quest Partners LLC acquired a new position in shares of Owens & Minor in the fourth quarter valued at about $41,000. 98.04% of the stock is owned by institutional investors.

About Owens & Minor

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.